East Ventures names new partner for South Korea fund
DeeperDive is a beta AI feature. Refer to full articles for the facts.
EAST Ventures has appointed Sang Han, former managing director of Temasek Life Sciences Accelerator (TLA), as partner for its South Korean fund.
TLA is a joint venture between Temasek Life Sciences Laboratory and Vertex Holdings.
Prior to TLA, Sang was with Vertex Venture Holdings for nearly a decade. In his new role, he will manage the fund operation of East Ventures in South Korea. Sang’s experience spans two decades, overseeing corporate development and directing investments.
The move comes months after the venture capital firm partnered Seoul-headquartered SV Investment to launch a new fund dedicated to South-east Asian and South Korean investments.
The fund will have a US$100 million target and invest in startups and companies across key sectors, including biotech and healthcare, future mobility, green technology, and media and content.
East Ventures is an early backer of notable tech companies in the region including Tokopedia, Traveloka and ShopBack.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
‘Boring’ is the new black: The stars are aligning for a Singapore stock market revival
Near sell-out launches in March boost developer sales to 1,300 units after four slow months
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Genting Singapore’s Lim Kok Thay receives S$7.5 million pay package for FY2025